R. Tsunashima

发表

Prediction of pathologic complete response to sequential paclitaxel and 5‐fluorouracil/epirubicin/cyclophosphamide therapy using a 70‐gene classifier for breast cancers

T. Taguchi, Y. Tamaki, S. Noguchi, 2011, Cancer.

Development of a prediction model for lymph node metastasis in luminal A subtype breast cancer: the possibility to omit sentinel lymph node biopsy.

S. Noguchi, Seung Jin Kim, K. Shimazu, 2014, Cancer letters.

Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients

S. Noguchi, Seung Jin Kim, M. Shimoda, 2013, Breast Cancer Research and Treatment.

Lack of genomic rearrangements involving the aromatase gene CYP19A1 in breast cancer

T. Ogata, S. Noguchi, K. Nakabayashi, 2014, Breast Cancer.

MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide

Y. Tamaki, S. Noguchi, Seung Jin Kim, 2012, Breast Cancer Research and Treatment.

Construction of multi-gene classifier for prediction of response to and prognosis after neoadjuvant chemotherapy for estrogen receptor positive breast cancers.

S. Noguchi, Seung Jin Kim, K. Shimazu, 2015, Cancer letters.

70-Gene classifier for differentiation between paclitaxel- and docetaxel-sensitive breast cancers.

Y. Tamaki, S. Noguchi, T. Nakayama, 2012, Cancer letters.

Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients

T. Taguchi, Y. Tamaki, S. Noguchi, 2011, Breast Cancer Research and Treatment.

Endocrine sensitivity of estrogen receptor‐positive breast cancer is negatively correlated with aspartate‐β‐hydroxylase expression

J. Wands, S. Noguchi, Seung Jin Kim, 2017, Cancer science.

Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer.

S. Noguchi, K. Shimazu, Y. Sota, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

High genomic grade index associated with poor prognosis for lymph node‐negative and estrogen receptor‐positive breast cancers and with good response to chemotherapy

T. Taguchi, Y. Tamaki, S. Noguchi, 2011, Cancer.

[A case of curatively resected advanced intrahepatic cholangiocellular carcinoma through effective response to neoadjuvant chemotherapy].

T. Monden, S. Imaoka, J. Fujita, 2014, Gan to kagaku ryoho. Cancer & chemotherapy.

The multigene classifiers 95GC/42GC/155GC for precision medicine in ER‐positive HER2‐negative early breast cancer

S. Noguchi, K. Shimazu, Y. Naoi, 2021, Cancer science.

Estrogen receptor positive breast cancer identified by 95-gene classifier as at high risk for relapse shows better response to neoadjuvant chemotherapy.

Y. Tamaki, S. Noguchi, Seung Jin Kim, 2012, Cancer letters.

72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissues.

S. Noguchi, Seung Jin Kim, M. Shimoda, 2014, Clinical breast cancer.

Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients

S. Noguchi, Seung Jin Kim, T. Tanei, 2018, Breast Cancer Research and Treatment.

Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer.

Y. Naoi, K. Sakaguchi, Chikage Kato, 2023, Cancer treatment and research communications.

Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer.

S. Noguchi, Seung Jin Kim, K. Shimazu, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.